A Patient Guide To Rheumatoid Arthritis IV Infusions

An IV medication isn’t automatically a sign that rheumatoid arthritis is severe. It’s one way to deliver a targeted treatment when a rheumatologist determines that an infused biologic fits a patient’s disease history, current symptoms, prior medications, and overall health. For many people considering rheumatoid arthritis infusion therapy, the practical questions matter just as much as the medication itself: Why IV treatment? How long will the visit take? What happens if a reaction occurs?

We have more than 50 years of dedicated infusion experience, and our team completed more than 29,000 infusions for more than 8,000 patients in the past 12 months alone. At every visit, an on-site healthcare provider is assigned to supervise the infusion, and patients consult with an ARBDA healthcare provider before treatment begins. That level of clinical oversight matters because biologic treatment requires careful screening, monitoring, and ongoing communication with the ordering rheumatologist.

What Rheumatoid Arthritis Infusion Therapy Actually Does

Rheumatoid arthritis infusion therapy delivers a disease-modifying antirheumatic drug, often called a DMARD, directly into a vein. DMARDs are designed to reduce the immune activity driving joint inflammation and progressive damage, not simply provide short-term pain relief.

Many infused medicines are biologic response modifiers, meaning they target a specific part of the immune system involved in rheumatoid arthritis. A rheumatologist may consider one when conventional DMARDs haven’t controlled inflammation sufficiently, have caused unacceptable side effects, or aren’t appropriate for a patient’s medical situation.

IV treatment is only one delivery method. Some rheumatoid arthritis medicines are administered as subcutaneous injections into the fatty tissue beneath the skin. Cimzia is an injection, for example, while Simponi Aria is given by IV infusion. Route, schedule, and medication choice should come from an individual clinical evaluation, not from convenience alone.

Which Biologics May Be Used for Rheumatoid Arthritis

Different biologics act on different immune pathways. None is universally best, and a rheumatologist considers prior treatment response, infection history, other health conditions, laboratory findings, and treatment goals when selecting a medication.

TNF Inhibitors

Tumor necrosis factor alpha, often shortened to TNF-alpha, is an inflammatory protein that contributes to rheumatoid arthritis symptoms and joint damage. Infliximab (brand name Remicade) and golimumab (Simponi Aria for IV use) are TNF inhibitors that block this pathway. Infliximab typically involves doses at weeks 0, 2, and 6 before maintenance infusions, while Simponi Aria commonly begins with doses at weeks 0 and 4 followed by treatment approximately every 8 weeks, though the prescribed schedule can vary.

T Cell & Interleukin-6 Treatments

Abatacept (Orencia) affects T cell costimulation, a process that helps activate certain immune cells. Tocilizumab (Actemra) blocks the interleukin-6 receptor, targeting an inflammatory signaling pathway involved in rheumatoid arthritis. Both may be given on recurring schedules after an initial dosing phase, but infusion interval and monitoring depend on the medication and the patient’s response.

B Cell-Directed Treatment

Rituximab (Rituxan) depletes B cells, which are immune cells that contribute to the autoimmune activity involved in rheumatoid arthritis. A course often involves two infusions separated by about two weeks, with later courses determined by the rheumatologist’s treatment plan and clinical assessment.

Our New Jersey centers administer Remicade, Orencia, Actemra, Rituxan, and Simponi Aria when ordered by a patient’s treating provider. Some of these biologics also have biosimilars, which are highly similar versions of an approved biologic that meet regulatory standards for safety and effectiveness. Coverage requirements can influence whether a brand-name medicine or a biosimilar is used.

What Happens Before Your First Infusion

Preparation starts well before an IV is placed. The ordering rheumatologist and our infusion team review the referral, prescribed medication, medical history, current medicines, allergies, previous biologic use, and any instructions for the day of treatment. Screening for infection is also important before starting many biologics. Tuberculosis and hepatitis B screening checks for infections that may be inactive but could become more serious when immune activity is modified. Depending on the medicine and a patient’s history, the care team may also need laboratory results measuring blood counts, liver function, or other clinical markers.

Prior authorization is the insurer’s review process to confirm coverage requirements before a medication is dispensed. Our billing team works with the ordering physician on prior authorization and coverage verification, and we help patients explore applicable copay assistance programs. Processing time depends on the insurer, the medication, and whether additional records are requested.

Before each infusion at {Sub:BusinessName}, patients meet briefly with an ARBDA healthcare provider. We assign an on-site supervising healthcare provider to every infusion, not on-call from a separate floor and not limited to select visits. That provider reviews any concerns before treatment begins and remains available throughout the visit.

What to Expect During & After Treatment

The visit follows a consistent sequence: check-in, clinical review, IV placement, medication administration, observation, and discharge. Total time varies by medication, whether it’s a first dose, the prescribed infusion rate, and how a patient tolerates treatment. Some medicines also require premedication (such as acetaminophen or an antihistamine) when the ordering clinician determines it’s appropriate.

Patients should tell the care team immediately about hives, itching, breathing difficulty, chest discomfort, dizziness, nausea, chills, flushing, or any unusual change in how they feel. Staff can slow or stop an infusion and follow the clinical protocol if a concern arises.

Our treatment rooms include pillow-top recliners, individual televisions or tablets, snacks and beverages, warm blankets, power outlets, and high-speed Wi-Fi. Private rooms with natural light are also available.

After treatment, patients should follow the instructions provided by their care team and contact the appropriate clinician about any concerning symptoms, particularly signs of infection. Because biologics affect immune activity, a fever, persistent cough, painful urination, or a wound that isn’t healing shouldn’t be ignored. The rheumatologist remains central to assessing disease activity and deciding whether treatment should continue, change, or pause.

Costs, Scheduling, & Ongoing Monitoring

Out-of-pocket cost depends on the medication, insurance plan, deductible, coinsurance, network rules, authorization requirements, and eligibility for financial assistance. An outpatient infusion center is often a more affordable setting than a hospital-based infusion department, but coverage and personal responsibility must be confirmed for each individual plan. We help patients understand their expected costs before treatment begins and work to connect them with copay assistance programs that can reduce the financial burden.

Scheduling is shaped by the medicine’s dosing interval. A treatment given every four weeks creates a different routine than one given every eight weeks or in periodic courses. Patients should plan for regular rheumatology visits, laboratory monitoring when ordered, and communication about infections, new medications, vaccinations, or changes in health between infusions. Our team works directly with referring offices on authorization and referral coordination, and patients can reach us by phone Monday through Friday, 8:00 a.m. to 4:30 p.m., for scheduling, insurance, billing, and clinical questions. Our centers are located in Voorhees, Moorestown, Sewell, Brick, Hamilton, Galloway, and Haddon Heights.

Treatment Is Individual, Not Formulaic

Response to an infused biologic varies. Some people notice improvement after several treatments; others need more time or a change in medication. Consistent follow-up gives the rheumatologist the information needed to weigh disease activity, side effects, laboratory results, and day-to-day function and to adjust the plan when something isn’t working.

If your rheumatologist is considering biologic or IV treatment, we can help coordinate the next steps. Contact {Sub:BusinessName} at {F:P:Sub:Phone} to discuss referral coordination, insurance preparation, and scheduling your infusion visit.